Pharmacokinetics and Pharmacodynamics of Antifungals-Reference-Cited by-同舟云学术

Pharmacokinetics and Pharmacodynamics of Antifungals

Published:2006-09 Issue:3 Volume:20 Page:679-697
ISSN:0891-5520
Container-title:Infectious Disease Clinics of North America
language:en
Short-container-title:Infectious Disease Clinics of North America

Author:

Andes David

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference89 articles.

1. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men;Craig;Clin Infect Dis,1998

2. In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis;Andes;Antimicrob Agents Chemother,2003

3. Antimicrobial pharmacodynamics: critical interactions of ‘bug and drug’;Drusano;Nat Rev Microbiol,2004

4. Reference method for broth dilution antifungal susceptibility testing for yeast; approved standard. Document M27-A;National Committee for Clinical Laboratory Standards,1997

5. Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints;Pfaller;J Clin Microbiol,2006

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical pharmacology of antiinfective drugs;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Oteseconazole (Vivjoa): A CYP51 Inhibitor for Treating Recurrent Vulvovaginal Candidiasis;Chemistry and Pharmacology of Drug Discovery;2024-08-16

3. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review;International Journal of Antimicrobial Agents;2024-02

4. In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in Candida spp.;Journal of Fungi;2023-12-12

5. Antifungal prophylaxis in adult lung transplant recipients: Uncertainty despite 30 years of experience. A systematic review of the literature and network meta‐analysis;Transplant Infectious Disease;2022-04-07